Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
ADAR1 Partners Logo
ADAR1 Partners Growth Score
22
Heat Score
18
ADAR1 Partners operates as an investment firm.
Private
Overview

ADAR1 Partners
Growth Score
22
Heat Score
18

Growth Score22
-3 pts
in past quarter
Heat Score 18
-2 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About ADAR1 Partners

ADAR1 Partners operates as an investment firm.
Private

Details

Operating Status Active
Number of Exits 
obfuscation
About the Company
ADAR1 Partners operates as an investment firm.
Investor Type 
obfuscation
Investment Stage 
obfuscation
Predictions & Insights

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Investments

Number of Investments 5
Number of Exits 
obfuscation
See investment data for this company, with details on deal size, industry, stage, and more.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
Grace Therapeutics (formerly Acasti Pharma) Logo
Grace Therapeutics (formerly Acasti Pharma)
Yes
Post-IPO Equity - Grace Therapeutics (formerly Acasti Pharma) Logo
Post-IPO Equity - Grace Therapeutics (formerly Acasti Pharma)
obfuscation
obfuscation
Grace Therapeutics (formerly Acasti Pharma) Logo
Grace Therapeutics (formerly Acasti Pharma)
Yes
Post-IPO Equity - Grace Therapeutics (formerly Acasti Pharma) Logo
Post-IPO Equity - Grace Therapeutics (formerly Acasti Pharma)
obfuscation
obfuscation
Grace Therapeutics (formerly Acasti Pharma) Logo
Grace Therapeutics (formerly Acasti Pharma)
Yes
Post-IPO Equity - Grace Therapeutics (formerly Acasti Pharma) Logo
Post-IPO Equity - Grace Therapeutics (formerly Acasti Pharma)
obfuscation
obfuscation
Grace Therapeutics (formerly Acasti Pharma) Logo
Grace Therapeutics (formerly Acasti Pharma)
Yes
Post-IPO Equity - Grace Therapeutics (formerly Acasti Pharma) Logo
Post-IPO Equity - Grace Therapeutics (formerly Acasti Pharma)
obfuscation
obfuscation
Grace Therapeutics (formerly Acasti Pharma) Logo
Grace Therapeutics (formerly Acasti Pharma)
Yes
Post-IPO Equity - Grace Therapeutics (formerly Acasti Pharma) Logo
Post-IPO Equity - Grace Therapeutics (formerly Acasti Pharma)
obfuscation

Investment Breakdown

Number of Investments 5
Number of Exits 
obfuscation
See investment data for this company, with details on deal size, industry, stage, and more.
Announced Date  
Organization Name  
Lead Investor  
Funding Round  
Money Raised  
obfuscation
Grace Therapeutics (formerly Acasti Pharma) Logo
Grace Therapeutics (formerly Acasti Pharma)
Yes
Post-IPO Equity - Grace Therapeutics (formerly Acasti Pharma) Logo
Post-IPO Equity - Grace Therapeutics (formerly Acasti Pharma)
obfuscation
obfuscation
Grace Therapeutics (formerly Acasti Pharma) Logo
Grace Therapeutics (formerly Acasti Pharma)
Yes
Post-IPO Equity - Grace Therapeutics (formerly Acasti Pharma) Logo
Post-IPO Equity - Grace Therapeutics (formerly Acasti Pharma)
obfuscation
obfuscation
Grace Therapeutics (formerly Acasti Pharma) Logo
Grace Therapeutics (formerly Acasti Pharma)
Yes
Post-IPO Equity - Grace Therapeutics (formerly Acasti Pharma) Logo
Post-IPO Equity - Grace Therapeutics (formerly Acasti Pharma)
obfuscation
obfuscation
Grace Therapeutics (formerly Acasti Pharma) Logo
Grace Therapeutics (formerly Acasti Pharma)
Yes
Post-IPO Equity - Grace Therapeutics (formerly Acasti Pharma) Logo
Post-IPO Equity - Grace Therapeutics (formerly Acasti Pharma)
obfuscation
obfuscation
Grace Therapeutics (formerly Acasti Pharma) Logo
Grace Therapeutics (formerly Acasti Pharma)
Yes
Post-IPO Equity - Grace Therapeutics (formerly Acasti Pharma) Logo
Post-IPO Equity - Grace Therapeutics (formerly Acasti Pharma)
obfuscation

Diversity Investments

Number of Diversity Investments 1
Announced Date  
Organization Name  
Diversity Spotlight  
Funding Round  
Money Raised  
obfuscation
Outdoorsy Logo
Outdoorsy
Women Founded
Series D - Outdoorsy Logo
Series D - Outdoorsy
obfuscation
Market Intelligence
People
View Profiles & Contacts
News

News and Press

News•Feb 10, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 10, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 10, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report
Sub-Organizations
Frequently Asked Questions
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(411cf44 1)
|